Spyre Therapeutics (SYRE) Stock
Spyre Therapeutics (SYRE) closed at $93.81 on Nov 17, 2026; its Tenet Score is 43 of 100 against 340 Healthcare peers.
41 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $93.81
- Nov 17, 2026
- Market cap
- $9.4B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 22.13 – 110.64
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 43/100
- Weak · 340 Healthcare peers
Industry: Drugs
Spyre Therapeutics Inc. scores 43/100. Weak. Strongest on financial health, value is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 43 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ~ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
13F flows & insider trades land here.
Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Biomarin Pharmaceutical Inc.BMRN | 43 | $11.2B |
| Halozyme Therapeutics Inc.HALO | 71 | $11.0B |
| Kymera Therapeutics IncKYMR | 41 | $10.7B |
| Repligen Corp.RGEN | 49 | $10.4B |
| Madrigal Pharmaceuticals IncMDGL | 32 | $9.8B |
| TG Therapeutics IncTGTX | 43 | $9.6B |
| Krystal Biotech IncKRYS | 66 | $8.8B |
| Praxis Precision Medicines IncPRAX | 46 | $8.7B |
| Protagonist Therapeutics IncPTGX | 65 | $8.1B |
| Alkermes plcALKS | 37 | $7.8B |
Common questions
What sector and industry is Spyre Therapeutics in?
Spyre Therapeutics is in the Healthcare sector and the Drugs industry.
What is Spyre Therapeutics' Tenet Score?
Spyre Therapeutics' Tenet Score is 43 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




